$3.48
-0.08 (-2.25%)
Open$3.51
Previous Close$3.56
Day High$3.57
Day Low$3.43
52W High$216.37
52W Low—
Volume—
Avg Volume90.9K
Market Cap13.24M
P/E Ratio51.19
EPS$1,612.06
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 462.8K | 474.7K | 442.2K |
| Net Income | -17,156 | -18,549 | -17,491 |
| Profit Margin | -3.7% | -3.9% | -4.0% |
| EBITDA | -38,868 | -39,496 | -31,996 |
| Free Cash Flow | -11,585 | -14,526 | -17,935 |
| Rev Growth | +1.4% | -0.9% | -6.2% |
| Debt/Equity | 0.29 | 0.36 | 0.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 35.2 | 28.41B |